Skip to main content
ANAB logo

ANAB · Anaptysbio, Inc · Executive Compensation

Track ANAB — free
$46.63 -0.77 (-1.62%) At close · Nov 20
Market Cap
$1.39B
Shares
29.90M
Volume · Nov 20 432.48K Avg daily vol (3M) 494.29K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Daniel Faga $6,133,943
Paul Lizzul $2,365,377
Dennis Mulroy $2,007,927
Fiscal 2024
Executive Total
Daniel Faga $13,630,292
Paul Lizzul $4,583,508
Dennis Mulroy $3,238,907
Fiscal 2023
Executive Total
Daniel Faga $7,461,920
Paul Lizzul $2,441,117
Eric Loumeau $2,258,185
Dennis Mulroy $2,155,954
Fiscal 2022
Executive Total
Daniel Faga $24,440,350
Eric Loumeau $3,841,763
Paul Lizzul $3,812,528
Fiscal 2021
Executive Total
Hamza Suria $3,538,858
Paul Lizzul $1,699,078
Eric Loumeau $1,655,786
Fiscal 2020
Executive Total
Dennis Mulroy $1,622,853
Paul Lizzul $1,578,719
Hamza Suria $885,390
Eric Loumeau $725,338
Fiscal 2019
Executive Total
Hamza Suria $7,875,186
Dominic G. Piscitelli $1,855,658
Fiscal 2018
Executive Total
Hamza Suria $5,122,232
Marco Londei $2,513,740
Eric Loumeau $2,165,031
Dominic G. Piscitelli $2,115,705
Fiscal 2017
Executive Total
Hamza Suria $4,016,438
Dominic G. Piscitelli $2,871,248
Marco Londei $2,150,857

Executive changes

Person Change Filed
Owen Hughes Appointed 2026-05-11
Christopher M. Murphy Appointed 2026-05-11
J. Anthony Ware Resigned 2026-04-20
Magda Marquet Resigned 2026-04-20
Rita Jain Resigned 2026-04-20
Dennis Fenton Resigned 2026-04-20
Susannah Gray Appointed 2026-03-27
Tony Ware Appointed 2026-03-27
Rita Jain Appointed 2026-03-27
Magda Marquet Appointed 2026-03-27
John Orwin Appointed 2026-03-27
John Schmid Appointed 2026-03-27
Dennis Fenton Appointed 2026-03-27
Daniel Faga Appointed 2026-03-27
Ajim Tamboli Appointed 2026-03-27
Daniel Faga Appointed 2026-03-27
Eric Loumeau Terminated 2026-03-27
Dennis Mulroy Terminated 2026-03-27
Susannah Gray Appointed 2026-03-27
John Orwin Appointed 2023-09-18
John Orwin Appointed 2023-09-18
James N. Topper, M.D., Ph.D.
“Dr. Topper’s resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2023-09-18
James N. Topper, M.D., Ph.D.
“Dr. Topper’s resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2023-09-18
Rita Jain, M.D. Appointed 2023-04-06
Laura J. Hamill
“Ms. Hamill’s resignation is not the result of any disagreement with the Company on any matter relating to its operations, policies or practices.”
Resigned 2023-04-06

Leadership

Key facts CIK 1370053 CUSIP 032724106 13F (30d) 230 filings 211 filers Visit website Investor relations